Condoms act as a barrier contraceptive and do not have any impact on ovulation, therefore they do not cause any delay in fertility. The intrauterine system (IUS) functions by thickening cervical mucous and may prevent ovulation in some women, but most women still ovulate. Once the IUS is removed, most women regain their fertility immediately.

The combined oral contraceptive pill may postpone the return to a normal menstrual cycle in some women, but the majority of them can conceive within a month of discontinuing it. The progesterone-only pill is less likely to delay the return to a normal cycle as it does not contain oestrogen.

Depo-Provera can last up to 12 weeks, and it may take several months for the body to return to a normal menstrual cycle, which can delay fertility. As a result, it is not the most suitable method for a woman who wants to resume ovulatory cycles immediately.

Injectable Contraceptives: Depo Provera

Injectable contraceptives are a popular form of birth control in the UK, with Depo Provera being the main option available. This contraceptive contains 150mg of medroxyprogesterone acetate and is administered via intramuscular injection every 12 weeks. It can be given up to 14 weeks after the last dose without the need for extra precautions. The primary method of action is by inhibiting ovulation, while secondary effects include cervical mucus thickening and endometrial thinning.

However, there are some disadvantages to using Depo Provera. Once the injection is given, it cannot be reversed, and there may be a delayed return to fertility of up to 12 months. Adverse effects may include irregular bleeding and weight gain, and there is a potential increased risk of osteoporosis. It should only be used in adolescents if no other method of contraception is suitable.

It is important to note that there are contraindications to using Depo Provera, such as current breast cancer (UKMEC 4) or past breast cancer (UKMEC 3). While Noristerat is another injectable contraceptive licensed in the UK, it is rarely used in clinical practice and is given every 8 weeks. Overall, injectable contraceptives can be an effective form of birth control, but it is important to weigh the potential risks and benefits before deciding on this method.

Differential Diagnosis for a Patient with Cough and Fever: Bronchopneumonia vs. Other Conditions

Bronchopneumonia is a common condition that presents with a cough and fever, along with other symptoms such as sputum production, dyspnea, and pleuritic pain. Examination findings may include decreased breath sounds and focal chest signs. A chest radiograph can confirm the diagnosis. In primary care, a CRB-65 score is used to assess mortality risk and determine where to treat the patient: one point each for acute confusion, respiratory rate (RR) ≥30/min, systolic blood pressure (BP) <90 mmHg or diastolic BP <60 mmHg, age >65 years).
CRB-65 score Mortality risk (%) – Where to treat
0 <1 At home
1-2 1-10 Hospital advised, particularly score of 2
3-4 >10 Hospital advised, may require stay in intensive therapy unit (ITU).

Other conditions that may present with similar symptoms include pneumothorax, pulmonary embolism, malignant mesothelioma, and tuberculosis. However, these conditions have distinct features that differentiate them from bronchopneumonia. For example, pneumothorax involves partial or full collapse of a lung, while pulmonary embolism results from obstruction of one or more of the pulmonary arteries. Malignant mesothelioma is a cancer that affects the pleura and peritoneum, and tuberculosis usually presents with a persistent productive cough, weight loss, night sweats, fevers, lymphadenopathy, and general malaise.

It is important to consider these differentials when evaluating a patient with cough and fever, and to use appropriate diagnostic tools to confirm the diagnosis and determine the best course of treatment.

Differentiating between medical conditions based on breath scent

When a comatose patient presents with a distinct scent on their breath, it can be a helpful clue in determining the underlying medical condition. The smell of acetone is strongly indicative of diabetic ketoacidosis (DKA), which is commonly seen in patients with poorly controlled type I diabetes. In contrast, alcohol intoxication produces a scent of alcohol rather than a fruity odor. Diabetic hyperosmolar coma, typically seen in older patients with type II diabetes, does not produce a specific scent as there is no acetone production. Heroin overdose and profound hypoglycemia also do not result in a distinct breath scent. Understanding the different scents associated with various medical conditions can aid in prompt and accurate diagnosis.

Autoimmune Antibodies and Their Associated Conditions

Autoimmune disorders are conditions in which the immune system mistakenly attacks the body’s own tissues. One way to diagnose autoimmune disorders is by testing for specific antibodies that are associated with certain conditions. Here are some common autoimmune antibodies and the conditions they are associated with:

1. Anti-phospholipid antibodies: These antibodies are linked to anti-phospholipid syndrome (APS), also known as Hughes’ syndrome. APS can cause blood clots and pregnancy-related complications.

2. Anti-endomysial antibodies: These antibodies are associated with coeliac disease, an autoimmune disorder that affects the small intestine.

3. Anti-histone antibodies: These antibodies are linked to drug-induced systemic lupus erythematosus (SLE), another autoimmune disorder.

4. Anti-mitochondrial antibodies: These antibodies are associated with primary biliary cholangitis, autoimmune hepatitis, and idiopathic cirrhosis, all of which affect the liver.

5. Anti-nuclear antibodies: These antibodies are associated with several autoimmune disorders, including SLE, autoimmune hepatitis, Sjögren’s syndrome, systemic sclerosis, and rheumatoid arthritis.

Testing for these antibodies can help diagnose autoimmune disorders and guide treatment.

The use of clindamycin as a treatment is strongly linked to an increased likelihood of contracting C. difficile.

Clostridioides difficile is a type of bacteria that is commonly found in hospitals. It is a Gram positive rod that produces an exotoxin which can cause damage to the intestines, leading to a condition called pseudomembranous colitis. This bacteria usually develops when the normal gut flora is suppressed by broad-spectrum antibiotics, with second and third generation cephalosporins being the leading cause of C. difficile. Other risk factors include proton pump inhibitors. Symptoms of C. difficile include diarrhea, abdominal pain, and a raised white blood cell count. The severity of the infection can be determined using the Public Health England severity scale, which ranges from mild to life-threatening.

To diagnose C. difficile, a stool sample is tested for the presence of C. difficile toxin (CDT). Treatment for a first episode of C. difficile infection typically involves oral vancomycin for 10 days, with fidaxomicin or a combination of oral vancomycin and IV metronidazole being used as second and third-line therapies. Recurrent infections occur in around 20% of patients, increasing to 50% after their second episode. In such cases, oral fidaxomicin is recommended within 12 weeks of symptom resolution, while oral vancomycin or fidaxomicin can be used after 12 weeks. For life-threatening C. difficile infections, oral vancomycin and IV metronidazole are used, and surgery may be considered with specialist advice. Other therapies, such as bezlotoxumab and fecal microbiota transplant, may also be considered for preventing recurrences in certain cases.

Common Genitourinary Infections: Symptoms and Diagnosis

Trichomoniasis, Candidiasis, AIDS, HPV, and Lactobacilli infection are some of the most common genitourinary infections. Trichomoniasis is caused by Trichomonas vaginalis and presents with abnormal vaginal discharge, odour, itching, burning, soreness, and dyspareunia. Candidiasis is a fungal infection caused by yeasts from the genus Candida and presents with pruritus, vaginal discharge, dysuria, and dyspareunia. AIDS is a viral infection that has a hyperacute onset and is unlikely in patients with no past medical history or risk factors. HPV infection is common and often goes unnoticed, but can manifest as warty lesions on the genital or anal area. Lactobacilli infection is not associated with causing infection. Diagnosis of these infections depends on laboratory testing, with culture being the current criterion standard for trichomoniasis and physical examination for candidiasis.

Understanding the Causes of Dystonic Reactions: A Comparison of Common Drugs

Metoclopramide, carbamazepine, cyclopentolate, lidocaine, and procyclidine are all drugs that can cause various side effects, including disturbances in eye movement. However, when it comes to dystonic reactions, metoclopramide and procyclidine are the most likely culprits. Metoclopramide, commonly used for nausea and vomiting, can induce acute dystonic reactions involving facial and skeletal muscle spasms and oculogyric crises. On the other hand, procyclidine, an anti-muscarinic drug, is useful in the immediate treatment of a drug-induced oculogyric crisis. Understanding the differences between these drugs and their potential side effects is crucial in providing appropriate treatment for patients experiencing dystonic reactions.

When a woman expresses interest in starting hormone replacement therapy (HRT), it is important to gather a detailed medical history to determine her menopausal status. This includes information about her last menstrual period (LMP) and any bleeding patterns leading up to it. Based on this information, it appears that the woman in question is peri-menopausal, as she has not been without a period for a full year.

The primary reason for starting HRT is to alleviate vasomotor symptoms, such as hot flashes. However, it may also be used to prevent osteoporosis in women who have been diagnosed with premature menopause.

For women who still have a uterus, HRT should consist of a combination of estrogen and progesterone. The progesterone is essential for reducing the risk of endometrial cancer, which can occur when estrogen is used alone. Women who have had a hysterectomy will typically receive continuous estrogen-only therapy.

The type of HRT prescribed will depend on the woman’s menopausal status. Those who have had their LMP within the past year should receive cyclical combined HRT, while those who have been without a period for at least a year or who have experienced premature menopause should receive continuous combined HRT.

For women who are unable or unwilling to take HRT, there are several non-hormonal treatments available for vasomotor symptoms. These include certain selective serotonin and noradrenaline reuptake inhibitors, clonidine, and gabapentin. However, sertraline is not effective for treating hot flashes. It is worth noting that the National Institute for Health and Clinical Excellence (NICE) does not recommend the use of herbal or complementary therapies for managing hot flashes and night sweats.

Hormone replacement therapy (HRT) involves a small dose of oestrogen and progestogen to alleviate menopausal symptoms. The indications for HRT have changed due to the long-term risks, and it is primarily used for vasomotor symptoms and preventing osteoporosis in younger women. HRT consists of natural oestrogens and synthetic progestogens, and can be taken orally or transdermally. Transdermal is preferred for women at risk of venous thromboembolism.

Oestrogen therapy must be continued for at least 5-10 years to maintain its benefits, including a decreased risk of fragility fractures. Starting oestrogen therapy immediately can prevent osteoporotic fractures in old age. Bisphosphonates are the first-line treatment for bone-sparing. HRT should not be prescribed solely for preventing osteoporosis, but a combination of oestrogen and progesterone should be used in women with a uterus. Patients who have a salpingo-oophorectomy should be monitored for hormone-related conditions. SSRIs, SNRIs, and clonidine should not be the first-line treatment for vasomotor symptoms alone. Vaginal oestrogen can be offered to women with urogenital atrophy, even if they are on systemic HRT.

For this patient, who has a low risk of having a baby with neural tube defects and is not at high risk of vitamin D deficiency, the standard care is recommended. This includes taking a daily supplement of 10 micrograms of vitamin D. There is no need for her to take folic acid 5mg or higher doses of vitamin D, as they exceed the recommended amount.

Antenatal care guidelines were issued by NICE in March 2008, which included specific points for the care of healthy pregnant women. Nausea and vomiting can be treated with natural remedies such as ginger and acupuncture on the ‘p6’ point, as recommended by NICE. Antihistamines, with promethazine as the first-line option according to the BNF, can also be used. Adequate vitamin D intake is crucial for the health of both the mother and baby, and women should be informed about this at their booking appointment. The Chief Medical Officer advises all pregnant and breastfeeding women to take a daily supplement containing 10 micrograms of vitamin D, with particular care taken for those at risk. In 2016, new guidelines were proposed by the Chief Medical Officer regarding alcohol consumption during pregnancy. The government now advises pregnant women not to drink any alcohol to minimize the risk of harm to the baby.